Yuwen P, Chen W, Lv H, et al. Albumin and surgical site infection risk in orthopaedics: a meta-analysis. BMC Surg 2017;17:7. doi: 10.1186/s12893-016-0186-6.

Wiglusz K, Trynda-Lemiesz L. Platinum drugs binding to human serum albumin: effect of non-steroidal anti-inflammatory drugs. J Photochem Photobiol Chem 2014;289:1-6. doi: 10.1016/j.jphotochem.2014.05.013.

Bernardi M, Ricci CS, Zaccherini G. Role of human albumin in the management of complications of liver cirrhosis. J Clin Exp Hepatol 2014;4:302-11. doi: 10.1016/j.jceh.2014.08.007.

Hosseini SN, Pirsa S, Farzi J. Biodegradable nano composite film based on modified starch-albumin/MgO; antibacterial, antioxidant and structural properties. Polym Test 2021;97:107182. doi: 10.1016/j.polymertesting.2021.107182.

Rahmani-Kukia N, Abbasi A, Pakravan N, Hassan ZM. Measurement of oxidized albumin: an opportunity for diagnoses or treatment of COVID-19. Bioorg Chem 2020;105:104429. doi: 10.1016/j.bioorg.2020.104429.

Nurdiansyah R, Rifa’i M, Widodo. A comparative analysis of serum albumin from different species to determine a natural source of albumin that might be useful for human therapy. J Taibah Univ Med Sci 2016;11:243-9. doi: 10.1016/j.jtumed.2016.04.003.

Sun C, Liu J, Yang N, Xu G. Egg quality and egg albumen property of domestic chicken, duck, goose, Turkey, quail, and pigeon. Poult Sci 2019;98:4516-21. doi: 10.3382/ps/pez259.

Zhuang Y, Xu Y, Wang H, et al. Preparation of pure egg albumen fiber through coaxial wet-spinning. Mater Lett 2019;253:63-6. doi: 10.1016/j.matlet.2019.06.035.

GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020;396:1204-22. doi: 10.1016/S0140-6736(20)30925-9.

Moon AM, Singal AG, Tapper EB. Contemporary epidemiology of chronic liver disease and cirrhosis. Clin Gastroenterol Hepatol 2020;18: 2650-66. doi: 10.1016/j.cgh.2019.07.060.

Villanueva A. Hepatocellular carcinoma. N Engl J Med 2019;380:1450-62. DOI: 10.1056/NEJMra1713263

Zucman-Rossi J, Villanueva A, Nault JC, Llovet JM. Genetic landscape and biomarkers of hepatocellular carcinoma. Gastroenterology 2015;149:1226-39.e4. DOI: 10.1053/j.gastro.2015.05.061.

Nault JC, Lhotellerie S, Caruso S, et al. High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions. Nat Commun 2013;4:2218. https://doi.org/10.1038/ncomms3218.

Davidson SM, Jonas O, Keibler MA, et al. Direct evidence for cancer‐cell‐autonomous extracellular protein catabolism in pancreatic tumors. Nat Med 2017;23:235‐41. doi: 10.1038/nm.4256.

Kamphorst JJ, Nofal M, Commisso C, et al. Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. Cancer Res 2015;75:544‐53. doi: 10.1158/0008-5472.CAN-14-2211.

Palm W, Park Y, Wright K, Pavlova NN, Tuveson DA, Thompson CB. The utilization of extracellular proteins as nutrients is suppressed by mTORC1. Cell 2015;162:259‐70. doi: 10.1016/j.cell.2015.06.017.

Angeli P, Ginès P, Wong F, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. J Hepatol 2015;62:968-74. doi: 10.1136/gutjnl-2014-308874.

Russ KB, Stevens TM, Singal AK. Acute kidney injury in patients with cirrhosis. J Clin Transl Hepatol 2015;3:195-204. doi: 10.14218/JCTH.2015.00015.

Sohn W, Ham CB, Kim NH, et al. Effect of acute kidney injury on the patients with hepatocellular carcinoma undergoing transarterial chemoembolization. PLoS ONE 2020;15: e0243780. doi: 10.1371/journal.pone.0243780.

Cholongitas E, Goulis I, Ioannidou M, Soulaidopoulos S, Chalevas P, Akriviadis E. Urine albumin-to-creatinine ratio is associated with the severity of liver disease, renal function and survival in patients with decompensated cirrhosis. Hepatol Int 2017;11:306-14. doi: 10.1007/s12072-016-9759-9.

Wu MT, He SY, ChenL, et al. Clinical and prognostic implications of pretreatment albumin to C-reactive protein ratio in patients with hepatocellular carcinoma. BMC Cancer 2019; 19: 538. https://doi.org/10.1186/s12885-019-5747-5.

Fan Y, Gu X, Gao Z. Prognostic value of C-reactive protein to albumin ratio in patients with hepatocellular carcinoma: a meta-analysis. Clin Res Hepatol Gastroenterol 2019; 44:241-3. https://doi.org/10.1016/j.clinre.2019.07.014.

Tsoris A, Marlar CA. Use of the Child Pugh score in liver disease. Treasure Island (FL): StatPearls Publishing; 2024.

Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol 2022 ;76:681-93. doi: 10.1016/j.jhep.2021.11.018.

Emenena I, Emenena B, Kweki AG, et al. Model for end stage liver disease (MELD) score: a tool for prognosis and prediction of mortality in patients with decompensated liver cirrhosis. Cureus 2023;15:e39267. doi: 10.7759/cureus.39267.

Núñez KG, Sandow T, Patel J, et al. Hypoalbuminemia is a hepatocellular carcinoma independent risk factor for tumor progression in low-risk bridge to transplant candidates. Cancers 2022;14:1684. doi: 10.3390/cancers14071684.

Fede G, D’Amico G, Arvaniti V, et al. Renal failure and cirrhosis: a systematic review of mortality and prognosis. J Hepatol 2012;56:810-8.

Le DC, Nguyen TM, Nguyen DH, Nguyen DT, Nguyen LTM. Survival outcome and prognostic factors among patients with hepatocellular carcinoma: a hospital-based study. Clin Med Insights Oncol 2023;17:11795549231178171. doi: 10.1177/11795549231178171.

Liao J, Liu J, Li C, Fan J, Wang Z. Albumin-bilirubin grade as a prognostic factor of hepatocellular carcinoma after treatment with orthotopic liver transplantation. Transl Cancer Res2019;8:1457-65.doi:10.21037/tcr.2019.07.52.

Kariyama K, Nouso K, Toyoda H, et al. Utility of FIB4-T as a prognostic factor for hepatocellular carcinoma. Cancers 2019;11:203. doi: 10.3390/cancers11020203.

Wu MT, He SY, Chen SL, et al. Clinical and prognostic implications of pretreatment albumin to C-reactive protein ratio in patients with hepatocellular carcinoma. BMC Cancer 2019;19: 538. doi: 10.1186/s12885-019-5747-5.

Hung HC, Lee JC, Wang YC, et al. Living-donor liver transplantation for hepatocellular carcinoma: impact of the MELD score and predictive value of NLR on survival. Curr Oncol 2022;29:3881-93. doi: 10.3390/curroncol29060310.